Motivity Signs Definitive Agreement to Acquire Calmanac, Taking Full Ownership of the ABA Stack It Has Been Building

Motivity has announced a definitive agreement to acquire Calmanac, a move that aims to unify two prominent teams within the Applied Behavior Analysis (ABA) sector under a single platform focused on clinical integrity. While the financial details of the transaction remain undisclosed, the acquisition marks a significant milestone in the ongoing collaboration between the two companies, which has been in place for several years. The deal was officially announced on May 22, 2026, and is expected to enhance the operational capabilities of ABA practices.

Motivity has established itself as a leader in clinical data collection, backed by $11 million in National Institutes of Health (NIH) research funding. Its platform is designed to provide real-time data and flexible program design, which are critical for delivering individualized treatment and achieving optimal clinical outcomes. Calmanac, on the other hand, was developed to address the operational complexities faced by larger ABA providers. Its foundation was built on the needs of one of the largest ABA organizations in the United States, which required a system capable of handling intricate scheduling, billing, and authorization processes. This acquisition formalizes a partnership that has already proven successful in bridging the gap between clinical and operational functionalities.

The integration of Calmanac's enterprise-grade practice management capabilities with Motivity's clinical data collection system aims to create a seamless experience for ABA practitioners. Prior to the acquisition, the two platforms had already begun to work in tandem, providing a solution that allowed practices to manage both clinical and operational tasks without the need for multiple systems. This consolidation is expected to alleviate the challenges associated with managing disparate workflows and support teams, ultimately leading to improved outcomes for both practitioners and clients.

As the ABA sector continues to evolve, the demand for comprehensive solutions that address both clinical and operational needs has become increasingly apparent. The partnership between Motivity and Calmanac is a response to this market dynamic, providing a unified platform that eliminates the trade-offs between clinical excellence and operational efficiency. The merger is likely to set a new standard within the industry, as it emphasizes the importance of a clinically rigorous approach to practice management.

In conclusion, the acquisition of Calmanac by Motivity represents a strategic alignment that is poised to reshape the landscape of ABA technology solutions. By combining their strengths, the two companies aim to deliver a more integrated and effective platform for ABA providers, enhancing their ability to deliver high-quality care. As the market for ABA services expands, this acquisition may serve as a catalyst for further consolidation and innovation in the sector, ultimately benefiting practitioners and the families they serve.